Jean Drouin

Clarify Health Solutions, Inc. develops real-time care guidance technology solutions. Its platform connects patients, clinicians, and managers with an information they need; stratifies patients based on clinical and non-clinical characteristics; collects real-time data on patient?s progress; detects potential complications before they happen; and prompts patients and care providers to act. The company was founded by Jean Drouin and Todd J. Gottula in 2015 and is headquartered in San Francisco, CA.

Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then.